MedTrace Logo

Impact Nerium Oleander on Immune Function

NCT04486144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2021-04-22

No results posted yet for this study

Summary

Assess the impact of a proprietary extract of Nerium oleander on immune function as evidenced by COVID-19 symptoms and mortality in COVID-19 positive patients and their close contacts compared to controls that did not receive the extract.

Conditions

  • Covid19 Positive Patient
  • Covid19 Close Contact
  • Immune Function

Interventions

OTHER

Proprietary extract of Nerium oleander

This is a proprietary extract of Nerium oleander that is 6.25 ug per 0.5 ml of suspension. It is administered sublingually every six hours for 5 days. The daily dose is 25 ug and the 5 day dose is 125 ug.

Sponsors & Collaborators

  • HealthQuilt

    lead OTHER

Principal Investigators

  • Kim Dunn, MD, Ph.D. · KDunn and Associates, PA dba Healthquilt

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2020-07-23
Completion
2020-07-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04486144 on ClinicalTrials.gov